Tags

Type your tag names separated by a space and hit enter

Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
J Fam Pract 1999; 48(9):682-8JF

Abstract

BACKGROUND

The benefits of early detection of prostate cancer are uncertain, and the American College of Physicians and the American Academy of Family Physicians recommend individual decision making in prostate cancer screening. This study reports the knowledge of male primary care patients about prostate cancer and prostate-specific antigen (PSA) testing and examines how that knowledge is related to PSA testing, preferences for testing in the future, and desire for involvement in physician-patient decision making.

METHODS

The sample included 160 men aged 45 to 70 years with no history of prostate cancer who presented for care at a university-based family medicine clinic. Before scheduled office visits, patients completed a questionnaire developed for this study that included a 10-question measure of prostate cancer knowledge, the Deber-Kraestchmer Problem-Solving Decision-Making Scale, sociodemographic indicators, and questions on PSA testing.

RESULTS

In general, patients who were college graduates were more knowledgeable about prostate cancer and early detection than those with a high school education or less. Aside from college graduates, most patients could not identify the principle advantages and disadvantages of PSA testing. Patients indicating previous or future plans for PSA testing demonstrated greater knowledge than other patients. Desire for involvement in decision making varied by patient education but was not related to past PSA testing.

CONCLUSIONS

Patients lack knowledge about prostate cancer and early detection. This knowledge deficit may impede the early detection of prostate cancer and is a barrier to making an informed decision about undergoing PSA testing.

Authors+Show Affiliations

Clinical Science Center, University of Alabama School of Medicine-Huntsville Campus, 35801, USA.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

10498074

Citation

O'Dell, K J., et al. "Screening for Prostate Cancer With the Prostate-specific Antigen Test: Are Patients Making Informed Decisions?" The Journal of Family Practice, vol. 48, no. 9, 1999, pp. 682-8.
O'Dell KJ, Volk RJ, Cass AR, et al. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? J Fam Pract. 1999;48(9):682-8.
O'Dell, K. J., Volk, R. J., Cass, A. R., & Spann, S. J. (1999). Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? The Journal of Family Practice, 48(9), pp. 682-8.
O'Dell KJ, et al. Screening for Prostate Cancer With the Prostate-specific Antigen Test: Are Patients Making Informed Decisions. J Fam Pract. 1999;48(9):682-8. PubMed PMID: 10498074.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? AU - O'Dell,K J, AU - Volk,R J, AU - Cass,A R, AU - Spann,S J, PY - 1999/9/25/pubmed PY - 1999/9/25/medline PY - 1999/9/25/entrez SP - 682 EP - 8 JF - The Journal of family practice JO - J Fam Pract VL - 48 IS - 9 N2 - BACKGROUND: The benefits of early detection of prostate cancer are uncertain, and the American College of Physicians and the American Academy of Family Physicians recommend individual decision making in prostate cancer screening. This study reports the knowledge of male primary care patients about prostate cancer and prostate-specific antigen (PSA) testing and examines how that knowledge is related to PSA testing, preferences for testing in the future, and desire for involvement in physician-patient decision making. METHODS: The sample included 160 men aged 45 to 70 years with no history of prostate cancer who presented for care at a university-based family medicine clinic. Before scheduled office visits, patients completed a questionnaire developed for this study that included a 10-question measure of prostate cancer knowledge, the Deber-Kraestchmer Problem-Solving Decision-Making Scale, sociodemographic indicators, and questions on PSA testing. RESULTS: In general, patients who were college graduates were more knowledgeable about prostate cancer and early detection than those with a high school education or less. Aside from college graduates, most patients could not identify the principle advantages and disadvantages of PSA testing. Patients indicating previous or future plans for PSA testing demonstrated greater knowledge than other patients. Desire for involvement in decision making varied by patient education but was not related to past PSA testing. CONCLUSIONS: Patients lack knowledge about prostate cancer and early detection. This knowledge deficit may impede the early detection of prostate cancer and is a barrier to making an informed decision about undergoing PSA testing. SN - 0094-3509 UR - https://www.unboundmedicine.com/medline/citation/10498074/Screening_for_prostate_cancer_with_the_prostate_specific_antigen_test:_are_patients_making_informed_decisions L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=10498074.ui DB - PRIME DP - Unbound Medicine ER -